Keywords: nobilon, vivalis, ebx, licensing, accord, dutch, biopharmaceutical

Nobilon and Vivalis in EBx licensing accord

Article | 04 June 2007

Print This

Dutch biopharmaceutical firm Nobilon, which is a unit of Organon, has acquired rights to the EBx embryonic stem cell line ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in